Dr Ali Aminian (Director, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH, USA) kindly shared his thoughts on the association between obesity and COVID-19 and the results of his study on the association of prior metabolic surgery and bariatric surgery with COVID-19 severity from the virtual ESC Congress 2021. Questions What have we learned about […]

Dr Darryl Leong (Cardiologist, The Population Health Research Institute, McMaster University, Hamilton, ON, Canada) kindly shared his thoughts on the association between cardiometabolic risk factors and COVID-19 outcomes from the virtual ESC Congress 2021. Questions What has recent data taught us about the association between cardiometabolic risk factors and COVID-19 outcomes? (0.15) On the basis […]

Prof. Gilles Montalescot (Professor, Pitié-Salpêtrière Hospital, Paris, France) kindly shared his thoughts on the difficulty of treating heart failure after acute myocardial infarction, the use of firibastat and the QUORUM clinical study (NCT03715998) from the virtual ESC Congress 2021. Questions Why does heart failure after acute myocardial infarction remain so challenging to treat? (0.19) Could […]

Trudie Lobban (Founder and Trustee of the Arrhythmia Alliance, Chair of the HRC Organising Committee) introduces the A-A Heart Rhythm Congress 2021 (launching 3rd October 2021) and provides an overview of what to expect from this year’s meeting, why healthcare professionals should register, who can attend, and why the virtual platform will make this the […]

Available evidence from randomized studies suggests that most bifurcation lesions are best managed with a provisional stenting (PS) approach, as this is associated with fewer complications, simpler procedures and better outcomes, compared with elective double stenting.1–6 However, the Achilles’ heel of single-stent strategies is represented by a higher risk of suboptimal result on the side branch, […]

The first coronary stent was implanted by Sigwart and Puel in 1986.1 Coronary stents were initially used to treat failure of balloon angioplasty treatment, i.e. as bail-out for acute vessel closure (due to dissections) or restenosis (due to elastic recoil). After the BENESTENT and STRESS landmark randomized trials, the routine use of coronary stents for percutaneous […]

The true epidemiology of out-of-hospital cardiac arrest (OHCA) is difficult to define, with wide variations in reporting, management and outcomes worldwide.1,2 In Europe, the incidence of OHCA is estimated to be between 67 and 170 per 100,000 people and it continues to be a major public health challenge that is reliant on multiple links in a […]

Transcatheter-based therapies have become central to the treatment of valvular heart disease, particularly aortic stenosis.1–5 The first transcatheter aortic valve replacement (TAVR) was performed in 2002 and, in two short decades, TAVR has become a mainstay for the treatment of aortic stenosis for all surgical risk categories.1,6–8 With the global success and adoption of TAVR, significant efforts […]